ClinicalTrials.gg
Status unknownNCT03710512Updated Oct 18, 2018

Evaluation of Early Relapse After Mandibular Lengthening Surgery

An observational study in Mandibular Hypoplasia and Relapse, sponsored by Universitair Ziekenhuis Brussel. Status unknown at 1 site in Belgium. Open to participants aged 10 Years to 75 Years. Per ClinicalTrials.gov, last updated 2018-10-18.

Sponsored by Universitair Ziekenhuis Brussel · Observational

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
50
Ages
10 Years to 75 Years
Sex
All
01

Study summary

The goal of this study is to evaluate whether the use of a bone graft substitute at the osteotomy site will result in better stability and diminish early relapse after mandibular lengthening surgery.

The study focuses on the evaluation of the following hypothesis:

The use of bone graft substitute at the osteotomy site has an influence on:

  • The 3-dimensional stability of the osteotomy site
  • Early relapse based in the plasticity of the site
Read the detailed description

Bilateral sagittal split osteotomy (BSSO)of the mandible is a surgical procedure used to correct dentofacial discrepancies. Post-operative stability is of great concern for CMF (Cranio maxillo facial) surgeons as the goal is to achieve optimal functional outcomes, good aesthetic results and satisfaction of patients' concerns. Skeletal relapse is a known complication of mandibular lengthening surgery and is divided into two groups; short term or early relapse and long term or late relapse.

Short term relapse occurs within the first 6 to 8 weeks post-operatively and is due to intersegmental movement at the osteotomy site (osteotomy slippage) and osteosynthesis slippage. Late relapse is thought to be caused by progressive condylar resorption, a clinical entity affecting the temporomandibular joint.

The rationale to reconstruct the lateral cortical defect resulting from mandibular advancement with BSSO with a bone graft substitute lies in the prevention of an unaesthetic notching at the inferior border. The use of a self-hardening, space-occupying paste could add mechanical stability, thus increase 3D-stability at the osteotomy site and prevent early relapse.

The use of cone-beam computed tomography (CBCT) in the treatment planning and postoperative follow-up of orthognathic patients has provided the surgeons with a new three-dimensional imaging modality to evaluate the postoperative skeletal relapse and postoperative morphologic changes of the condyles. Skeletal relapse, as well as positional and dimensional changes of the condyles, can be quantified in three dimensions.

02

Conditions studied

  • Mandibular Hypoplasia
  • Relapse

Keywords

  • hydroset
03

In context

Micrognathism

26 studies on the registry are indexed under Micrognathism; 7 are open to participants now.

Browse Micrognathism studies →

Lead sponsor

Universitair Ziekenhuis Brussel is the lead sponsor of 375 studies on the registry; 107 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Class II occlusion of non-syndromic origin, mandibular hypoplasia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Class II occlusion of non-syndromic origin, mandibular hypoplasia
  • Availability of pre- and postoperative CBCT scans of sufficient quality
  • Age: >10years

Exclusion criteria

Exclusion Criteria:

  • Previous orthognathic surgical treatment
  • Simultaneously performed genioplasty
  • Plate osteosynthesis
  • Buccal plate fracture during surgery
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
50 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • hydroset

    patients receiving hydroset at osteotomy site

    Procedure: Bilateral sagittal split osteotomy

  • Control

    patients not receiving hydroset at osteotomy site

    Procedure: Bilateral sagittal split osteotomy

Interventions

  • ProcedureBilateral sagittal split osteotomy

    Bilateral sagittal split osteotomy of the mandible is a surgical procedure used to correct dentofacial discrepancies

06

What researchers measure

Primary outcomes

  1. early relapse by means of three dimensional color maps (CBCT)

    evaluation at the osteotomy gap, the position of the condyles, rami and chin

    Time frame: the first 6 months postoperatively

Secondary outcomes

  1. condylar resorption by means of three dimensional color maps (CBCT)

    a three-dimensional volumetric analysis of the condylar head and the glenoid cavity

    Time frame: the first 6 months postoperatively

07

Study locations

1 of 1 sites recruiting
  • Universitair Ziekenhuis Brussel
    Jette, Vlaams Brabant 1090, Belgium
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 18, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03710512
Responsible party
Veerle Van Mossevelde (Datanurse, Universitair Ziekenhuis Brussel) — Principal investigator
First posted
Oct 18, 2018
Start date
Sep 11, 2018
Primary completion
Sep 1, 2019 (estimated)
Completion
Dec 30, 2019 (estimated)
Last update
Oct 18, 2018

Study contacts

Veerle Van Mossevelde, Datanurse
Contact
veerle.vanmossevelde@uzbrussel.be
+32 2 476 31 34
Annelies De Cock, Datanurse
Contact
annelies.decock@uzbrussel.be
+32 2 474 99 06
Erica Coppey, MD
principal investigator · Universitair Ziekenhuis Brussel
Maurice Mommaerts, Prof. Mult
study director · Universitair Ziekenhuis Brussel

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion